WallStSmart

Elutia Inc. (ELUT)vsGE HealthCare Technologies Inc. (GEHC)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

GE HealthCare Technologies Inc. generates 175131% more annual revenue ($21.27B vs $12.14M). ELUT leads profitability with a 426.9% profit margin vs 9.3%. GEHC earns a higher WallStSmart Score of 65/100 (C+).

ELUT

Avoid

35

out of 100

Grade: F

Growth: 2.7Profit: 6.0Value: 4.7Quality: 5.0
Piotroski: 4/9Altman Z: -3.55

GEHC

Buy

65

out of 100

Grade: C+

Growth: 6.0Profit: 6.5Value: 5.7Quality: 4.5
Piotroski: 2/9Altman Z: 1.34
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ELUTFair Value (-0.0%)

Margin of Safety

-0.0%

Fair Value

$0.90

Current Price

$0.75

$0.15 premium

UndervaluedFair: $0.90Overvalued

Intrinsic value data unavailable for GEHC.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ELUT3 strengths · Avg: 9.3/10
Return on EquityProfitability
221.3%10/10

Every $100 of equity generates 221 in profit

Profit MarginProfitability
426.9%10/10

Keeps 427 of every $100 in revenue as profit

Price/BookValuation
2.1x8/10

Reasonable price relative to book value

GEHC1 strengths · Avg: 8.0/10
P/E RatioValuation
16.3x8/10

Attractively priced relative to earnings

Areas to Watch

ELUT4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$36.36M3/10

Smaller company, higher risk/reward

Revenue GrowthGrowth
-11.6%2/10

Revenue declined 11.6%

Free Cash FlowQuality
$-8.92M2/10

Negative free cash flow — burning cash

GEHC4 concerns · Avg: 2.8/10
PEG RatioValuation
1.774/10

Expensive relative to growth rate

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Free Cash FlowQuality
$-617.00M2/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth
1.342/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : ELUT

The strongest argument for ELUT centers on Return on Equity, Profit Margin, Price/Book. Profitability is solid with margins at 426.9% and operating margin at -243.1%.

Bull Case : GEHC

The strongest argument for GEHC centers on P/E Ratio.

Bear Case : ELUT

The primary concerns for ELUT are EPS Growth, Market Cap, Revenue Growth.

Bear Case : GEHC

The primary concerns for GEHC are PEG Ratio, Piotroski F-Score, Free Cash Flow.

Key Dynamics to Monitor

ELUT profiles as a declining stock while GEHC is a value play — different risk/reward profiles.

ELUT carries more volatility with a beta of 0.92 — expect wider price swings.

GEHC is growing revenue faster at 5.8% — sustainability is the question.

ELUT generates stronger free cash flow (-9M), providing more financial flexibility.

Bottom Line

GEHC scores higher overall (65/100 vs 35/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Elutia Inc.

HEALTHCARE · MEDICAL DEVICES · USA

Elutia Inc., a commercial-stage company, engages in developing and commercializing drug-eluting biomatrix technology to enhance surgical outcomes. The company is headquartered in Silver Spring, Maryland.

GE HealthCare Technologies Inc.

HEALTHCARE · MEDICAL DEVICES · USA

GE HealthCare Technologies Inc. provides medical technology, pharmaceutical diagnostics, and digital solutions in the United States. The company is headquartered in Chicago, Illinois.

Want to dig deeper into these stocks?